|
|
StartOut tallies the unrealized potential of LGBTQ entrepreneurs | | | San Francisco has accounted for nearly 80% of the total US funding for LGBTQ entrepreneurs over the last 20 years. (xavierarnau/Getty Images) | | | When investors choose where to put their money, they often use data as their guide. But that data doesn't always exist, especially when it comes to LGBTQ entrepreneurs. The StartOut Pride Economic Impact Index, a newly launched platform that quantifies the untapped opportunity in US-based LGBTQ entrepreneurs, hopes to change that: | | | | | | | Dealmaking, exit activity both slumped for European PE in Q2 | | After an early onslaught of cases, the coronavirus crisis appears to be receding in many European countries. That's welcome news for the region's private equity industry. The pandemic helped drive private equity deal volume in Europe to a seven-year low during the second quarter of the year, and exit value is on pace for its lowest annual total in six years. PitchBook's Q2 2020 European PE Breakdown examines the data behind those trends and many more, offering a full picture of how the pandemic has shaped the region's dealmaking scene. Other key takeaways include: - Private equity deal flow declined 31.5% in Q2 on a year-over-year basis
- Firms are raising fewer European private equity funds in 2020 than ever before
| | | | | | | Many corners of the real estate market are mired in uncertainty. But investors have been busy pumping billions into biotech properties. [The Wall Street Journal] The US government's response to the coronavirus pandemic has generated plenty of strong feelings. For McKinsey, it has also created a $100 million windfall. [ProPublica] For much of the region's history, the economy of what is now North Kosovo centered on mining. In the age of crypto, it's become a quarry of a different kind. [The Baffler] | | | | | |
|
| Since yesterday, the PitchBook Platform added: | 18 VC valuations | 1519 People | 389 Companies | 17 Funds | | | | | |
|
|
|
|
|
2010 Vintage Global Buyout Funds | | | | | |
|
PitchBook Webinar: Deal execution best practices | | On July 22 at 10 a.m. PT/1 p.m. ET, learn how you can close the right deals faster—even in a volatile market environment—using the detailed financial data available on the PitchBook Platform. Highlighting the best practices covered in the new PitchBook Deal Execution Guide, our experts will discuss: - Finding comparable private and public companies
- Conducting due diligence
- Researching precedent transactions
- Researching capital invested by industry, vertical and deal type
- Creating lists and connecting with buyers and investors
- Finding advisers and service providers
Register here to secure your spot. | | | | | | |
|
|
Mayfield names IndieBio founder as partner | | Arvind Gupta has been named partner at Mayfield to help the firm expand its engineering biology practice. Gupta will remain as a venture adviser at IndieBio, the biotech accelerator that he founded. Mayfield has also partnered with IndieBio's parent firm, SOSV, to create the Genesis Consortium, a group of funds and corporations focused on human and planetary evolution. | | | | | |
|
|
Udemy looks to claim $3B valuation with new funding | | Udemy, the provider of an online learning platform for students, businesses and governments, is pursuing a new funding round that could value the startup at $3 billion, according to The Information. The company, which is based in San Francisco but also operates in Denver, Brazil, India, Ireland and Turkey, was valued at $2 billion following a $50 million round from Japanese investor Benesse Holdings in February. | | | | | | Thrasio hits $1B valuation | | Ecommerce company Thrasio has raised $260 million at a $1 billion pre-money valuation in a Series C led by PE firm Advent International. The Massachusetts-based business is an acquirer of third-party sellers on Amazon and now owns a portfolio of more than 50 brands. It was valued at $675 million following a Series B in April, according to PitchBook data. | | | | | | CampusLogic gets $120M from Dragoneer | | Edtech startup CampusLogic has received a $120 million investment from Dragoneer Investment Group. Working with more than 750 colleges and universities, the company's platform provides a net price calculator, personalized digital communications, financial aid verification and other services for students. CampusLogic recently acquired RaiseMe, a startup focused on improving access to higher education for low-income and first-generation students. | | | | | | Caption Health grabs $53M for ultrasound tech | | | | | | | | | | Energy Impact Partners has led a $40 million Series D for NS1, which offers a platform to help companies such as Salesforce and LinkedIn manage cloud operations. Backed by investors including GGV Capital and Cisco, New York-based NS1 raised $33 million in October at a $228 million valuation, according to PitchBook data. | | | | | | | | | | NowRx has raised a $20 million Series B through equity crowdfunding platform SeedInvest. Based in Mountain View, Calif., NowRx operates digital pharmacy software intended to offer on-demand delivery of prescription medicines. The company has received prior funding from investors like Ulu Ventures and Logical Ventures. | | | | | | Gyant locks down $13.6M Series A | | Gyant, the provider of an AI-based digital health platform, has closed a $13.6 million round led by Wing Venture Capital. The San Francisco-based company will use the capital to advance its patient care technology, which has experienced heightened demand in hospitals during the coronavirus pandemic. | | | | | |
|
|
Relay eyes $380M upsized IPO | | Relay Therapeutics is looking to raise as much as $380 million after it amended the terms of its initial public offering. The number of shares increased to 20 million from 14.7 million, while the price range was boosted to $18 to $19 per share from $16 to $18. The Cambridge, Mass.-based company, which develops therapies to treat cancers, will debut on the Nasdaq. | | | | | |
|
|
Coelius Capital launches inaugural fund | | | | | |
|
|
"Late-stage VC deal count uncharacteristically outpaced the early stage in Q2, with particular strength in mega-deals as companies take advantage of high capital availability and investors looking to protect their largest and best investments." Source: Q2 2020 PitchBook-NVCA Venture Monitor | | | | | |
|